hydrocortisone + salbutamol

Hydrocortisone + salbutamol is a combination of two pharmaceutical agents used primarily in the management of acute and chronic respiratory conditions characterized by bronchospasm and airway inflammation. Hydrocortisone is a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties, acting mainly through glucocorticoid receptor agonism to reduce airway inflammation. Salbutamol (also known as albuterol) is a selective beta-2 adrenergic receptor agonist that acts as a bronchodilator, relaxing smooth muscle in the airways to relieve bronchospasm. The combination may be used in clinical settings such as acute asthma exacerbations or peri-intubation management for patients with reactive airway disease, where both rapid bronchodilation (from salbutamol) and reduction of inflammatory response (from hydrocortisone) are desired[3][7][9]. While each drug can be administered separately, their combined use has been shown to have additive effects on improving lung function during severe obstructive episodes[9]. However, the onset of action differs—salbutamol acts within minutes while intravenous hydrocortisone’s effect may take several hours[7][9].

Other names

hydrocortisone and salbutamolhydrocortisone plus salbutamol